Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8708 | 1157 | 26.7 | 68% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CA 19 9 | Author keyword | 60 | 38% | 11% | 128 |
2 | CA19 9 | Author keyword | 31 | 29% | 8% | 90 |
3 | SPAN 1 | Author keyword | 19 | 76% | 1% | 13 |
4 | CA242 | Author keyword | 17 | 100% | 1% | 8 |
5 | CA 50 | Author keyword | 16 | 60% | 2% | 18 |
6 | CA 72 4 | Author keyword | 13 | 47% | 2% | 21 |
7 | CARBOHYDRATE ANTIGEN 19 9 | Author keyword | 12 | 30% | 3% | 34 |
8 | CA 242 | Author keyword | 11 | 47% | 1% | 17 |
9 | DU PAN 2 | Author keyword | 10 | 58% | 1% | 11 |
10 | CA 195 | Author keyword | 9 | 83% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CA 19 9 | 60 | 38% | 11% | 128 | Search CA+19+9 | Search CA+19+9 |
2 | CA19 9 | 31 | 29% | 8% | 90 | Search CA19+9 | Search CA19+9 |
3 | SPAN 1 | 19 | 76% | 1% | 13 | Search SPAN+1 | Search SPAN+1 |
4 | CA242 | 17 | 100% | 1% | 8 | Search CA242 | Search CA242 |
5 | CA 50 | 16 | 60% | 2% | 18 | Search CA+50 | Search CA+50 |
6 | CA 72 4 | 13 | 47% | 2% | 21 | Search CA+72+4 | Search CA+72+4 |
7 | CARBOHYDRATE ANTIGEN 19 9 | 12 | 30% | 3% | 34 | Search CARBOHYDRATE+ANTIGEN+19+9 | Search CARBOHYDRATE+ANTIGEN+19+9 |
8 | CA 242 | 11 | 47% | 1% | 17 | Search CA+242 | Search CA+242 |
9 | DU PAN 2 | 10 | 58% | 1% | 11 | Search DU+PAN+2 | Search DU+PAN+2 |
10 | CA 195 | 9 | 83% | 0% | 5 | Search CA+195 | Search CA+195 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CA 19 9 | 135 | 40% | 23% | 267 |
2 | CA19 9 | 93 | 45% | 13% | 156 |
3 | CA 72 4 | 39 | 54% | 4% | 50 |
4 | CA 50 | 33 | 61% | 3% | 35 |
5 | CARBOHYDRATE ANTIGEN 19 9 | 25 | 52% | 3% | 34 |
6 | SERUM CA 19 9 | 23 | 62% | 2% | 24 |
7 | CA 19 9 LEVELS | 21 | 57% | 2% | 25 |
8 | CANCER ASSOCIATED ANTIGEN | 18 | 55% | 2% | 23 |
9 | CA242 | 11 | 67% | 1% | 10 |
10 | CA72 4 | 10 | 61% | 1% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association | 2014 | 13 | 62 | 77% |
THE CLINICAL UTILITY OF THE CA 19-9 TUMOR-ASSOCIATED ANTIGEN | 1990 | 320 | 36 | 94% |
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer | 2007 | 187 | 50 | 72% |
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report | 2010 | 71 | 55 | 33% |
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer | 2013 | 40 | 77 | 22% |
Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer | 2006 | 62 | 49 | 47% |
CA 19-9 as a marker for gastrointestinal cancers: a review | 1998 | 69 | 35 | 69% |
Extraordinarily elevated CA19-9 in benign conditions: A case report and review of the literature | 2001 | 46 | 9 | 67% |
Extraordinarily elevated serum levels of CA 19-9 and rapid decrease after succesfull therapy: A case report and review of literature | 2010 | 9 | 15 | 80% |
Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview | 2011 | 39 | 47 | 28% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC IMMUNODIAGNOST | 1 | 50% | 0.2% | 2 |
2 | UO CHIRURG ONCOL | 1 | 50% | 0.2% | 2 |
3 | AKAD SJUKHUSET ONCOL | 1 | 50% | 0.1% | 1 |
4 | AKL | 1 | 50% | 0.1% | 1 |
5 | CLIN GEN ONCOL SURG | 1 | 50% | 0.1% | 1 |
6 | CORE TECHNOL IL 1 018 | 1 | 50% | 0.1% | 1 |
7 | ENDOCRINOL HEAD NECK SURG | 1 | 50% | 0.1% | 1 |
8 | ETIOL TUMOR MARKERS | 1 | 50% | 0.1% | 1 |
9 | GASZTROENTEROL | 1 | 50% | 0.1% | 1 |
10 | HEPATO PANCREATO BILIARY UNIT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000204780 | CA 242//PREOPERATIVE CEA LEVEL//POSTOPERATIVE SURVEILLANCE |
2 | 0.0000122922 | CA 15 3//CA 153//TISSUE POLYPEPTIDE SPECIFIC ANTIGEN |
3 | 0.0000109025 | FUCOSYLTRANSFERASE//LEWIS Y ANTIGEN//FUT2 |
4 | 0.0000098117 | CA 125//HE4//HUMAN EPIDIDYMIS PROTEIN 4 |
5 | 0.0000083438 | CYFRA 21 1//CYTOKERATIN 19 FRAGMENTS//PROGRP |
6 | 0.0000081055 | PANCREATIC JUICE//K RAS POINT MUTATION//K RAS MUTATION |
7 | 0.0000077104 | PANCREATIC CANCER//BORDERLINE RESECTABLE//LOCALLY ADVANCED PANCREATIC CANCER |
8 | 0.0000076351 | CEACAM1//BILIARY GLYCOPROTEIN//CD66A |
9 | 0.0000075599 | PANCREAS NEOPLASMS//STAGING LAPAROSCOPY//LAPAROSCOPIC ULTRASOUND |
10 | 0.0000059027 | ADVANCED PANCREATIC CANCER//FOLFIRINOX//METASTATIC PANCREATIC CANCER |